Compare SUVEN LIFE with Torrent Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SUVEN LIFESCIENCES vs TORRENT PHARMA - Comparison Results

TORRENT PHARMA 
   Change

Torrent Pharmaceuticals Ltd. is the flagship company of the Torrent Group set up in 1959. Based in Ahmedabad, it was promoted by Mr U.N. Mehta initially as Trinity Laboratories Ltd. and was later renamed to its current name. The company derives its r... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SUVEN LIFESCIENCES TORRENT PHARMA SUVEN LIFESCIENCES/
TORRENT PHARMA
 
P/E (TTM) x 2.2 39.1 5.8% View Chart
P/BV x 0.5 8.5 6.2% View Chart
Dividend Yield % 4.4 0.7 611.9%  

Financials

 SUVEN LIFESCIENCES   TORRENT PHARMA
EQUITY SHARE DATA
    SUVEN LIFESCIENCES
Mar-19
TORRENT PHARMA
Mar-19
SUVEN LIFESCIENCES/
TORRENT PHARMA
5-Yr Chart
Click to enlarge
High Rs3381,964 17.2%   
Low Rs1691,245 13.6%   
Sales per share (Unadj.) Rs52.1453.4 11.5%  
Earnings per share (Unadj.) Rs6.825.8 26.5%  
Cash flow per share (Unadj.) Rs8.662.3 13.8%  
Dividends per share (Unadj.) Rs1.5017.00 8.8%  
Dividend yield (eoy) %0.61.1 55.8%  
Book value per share (Unadj.) Rs65.3279.2 23.4%  
Shares outstanding (eoy) m127.28169.22 75.2%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.93.5 137.5%   
Avg P/E ratio x37.162.2 59.6%  
P/CF ratio (eoy) x29.625.8 114.8%  
Price / Book Value ratio x3.95.7 67.6%  
Dividend payout %22.065.9 33.3%   
Avg Mkt Cap Rs m32,272271,513 11.9%   
No. of employees `0001.113.6 8.0%   
Total wages/salary Rs m66114,038 4.7%   
Avg. sales/employee Rs Th6,132.25,642.6 108.7%   
Avg. wages/employee Rs Th611.11,032.4 59.2%   
Avg. net profit/employee Rs Th803.5320.9 250.4%   
INCOME DATA
Net Sales Rs m6,63576,728 8.6%  
Other income Rs m242571 42.5%   
Total revenues Rs m6,87777,299 8.9%   
Gross profit Rs m1,60419,831 8.1%  
Depreciation Rs m2216,177 3.6%   
Interest Rs m385,038 0.7%   
Profit before tax Rs m1,5879,187 17.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-3,570 0.0%   
Tax Rs m7181,254 57.3%   
Profit after tax Rs m8694,363 19.9%  
Gross profit margin %24.225.8 93.5%  
Effective tax rate %45.213.6 331.5%   
Net profit margin %13.15.7 230.4%  
BALANCE SHEET DATA
Current assets Rs m6,23250,375 12.4%   
Current liabilities Rs m1,49051,653 2.9%   
Net working cap to sales %71.5-1.7 -4,291.6%  
Current ratio x4.21.0 428.8%  
Inventory Days Days8692 93.9%  
Debtors Days Days8368 120.9%  
Net fixed assets Rs m4,04383,648 4.8%   
Share capital Rs m127846 15.0%   
"Free" reserves Rs m8,18346,397 17.6%   
Net worth Rs m8,31047,244 17.6%   
Long term debt Rs m1839,129 0.0%   
Total assets Rs m10,389141,209 7.4%  
Interest coverage x43.12.8 1,526.6%   
Debt to equity ratio x00.8 0.3%  
Sales to assets ratio x0.60.5 117.5%   
Return on assets %8.76.7 131.2%  
Return on equity %10.59.2 113.3%  
Return on capital %19.512.3 158.2%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m5,62222,103 25.4%   
Fx outflow Rs m1,7995,522 32.6%   
Net fx Rs m3,82216,581 23.1%   
CASH FLOW
From Operations Rs m35617,981 2.0%  
From Investments Rs m-279-2,413 11.5%  
From Financial Activity Rs m-225-13,145 1.7%  
Net Cashflow Rs m-1482,380 -6.2%  

Share Holding

Indian Promoters % 63.4 71.5 88.7%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 7.0 -  
FIIs % 0.0 12.6 -  
ADR/GDR % 0.0 0.0 -  
Free float % 36.5 8.8 414.8%  
Shareholders   37,287 26,511 140.6%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SUVEN LIFESCIENCES With:   WOCKHARDT  TTK HEALTHCARE  ORCHID PHARMA LTD  BIOCON   J.B.CHEMICALS  

Compare SUVEN LIFESCIENCES With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 224 Points Higher; Realty and Oil & Gas Stocks Witness Buying(Closing)

Indian share markets witnessed buying interest during closing hours today and ended on a positive note.

Related Views on News

TORRENT PHARMA Announces Quarterly Results (3QFY20); Net Profit Up 2.0% (Quarterly Result Update)

Jan 28, 2020 | Updated on Jan 28, 2020

For the quarter ended December 2019, TORRENT PHARMA has posted a net profit of Rs 3 bn (up 2.0% YoY). Sales on the other hand came in at Rs 20 bn (down 4.1% YoY). Read on for a complete analysis of TORRENT PHARMA's quarterly results.

TORRENT PHARMA Announces Quarterly Results (2QFY20); Net Profit Up 36.3% (Quarterly Result Update)

Nov 1, 2019 | Updated on Nov 1, 2019

For the quarter ended September 2019, TORRENT PHARMA has posted a net profit of Rs 2 bn (up 36.3% YoY). Sales on the other hand came in at Rs 20 bn (up 5.9% YoY). Read on for a complete analysis of TORRENT PHARMA's quarterly results.

SUVEN LIFESCIENCES Announces Quarterly Results (1QFY20); Net Profit Up 47.2% (Quarterly Result Update)

Aug 28, 2019 | Updated on Aug 28, 2019

For the quarter ended June 2019, SUVEN LIFESCIENCES has posted a net profit of Rs 572 m (up 47.2% YoY). Sales on the other hand came in at Rs 2 bn (up 3.8% YoY). Read on for a complete analysis of SUVEN LIFESCIENCES's quarterly results.

TORRENT PHARMA Announces Quarterly Results (1QFY20); Net Profit Up 32.5% (Quarterly Result Update)

Jul 25, 2019 | Updated on Jul 25, 2019

For the quarter ended June 2019, TORRENT PHARMA has posted a net profit of Rs 2 bn (up 32.5% YoY). Sales on the other hand came in at Rs 20 bn (up 8.0% YoY). Read on for a complete analysis of TORRENT PHARMA's quarterly results.

SUVEN LIFESCIENCES 2018-19 Annual Report Analysis (Annual Result Update)

Jul 22, 2019 | Updated on Jul 22, 2019

Here's an analysis of the annual report of SUVEN LIFESCIENCES for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of SUVEN LIFESCIENCES. Also includes updates on the valuation of SUVEN LIFESCIENCES.

More Views on News

Most Popular

6 Charts Showing the State of Indian Financial Markets in 2020(Sector Info)

May 26, 2020

Six charts showing how Indian financial markets have performed in 2020 so far...

This 'Essential Product' Smallcap is a Must Have for a 'Covid-19' Immune Portfolio(Profit Hunter)

May 19, 2020

This smallcap company needs no stimulus measures to do well in the long term.

What the RBI's Rate Cut Means for Options Traders(Fast Profits Daily)

May 25, 2020

The RBI governor has cut the repo rate to 4%. What does this mean for options traders? Find out in this video.

Which Stocks Should You Buy, Sell, and Hold in the Market Today?(Profit Hunter)

May 21, 2020

The coronavirus led uncertainty refuses to go away from the markets. Here's what retail investors should do with their stocks...

More

India's #1 Trader
Reveals His Secrets

The Secret to Increasing Your Trading Profits Today
Get this Special Report, The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

SUVEN LIFESCIENCES SHARE PRICE


May 29, 2020 (Close)

TRACK SUVEN LIFESCIENCES

  • Track your investment in SUVEN LIFESCIENCES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON SUVEN LIFESCIENCES

SUVEN LIFESCIENCES 8-QTR ANALYSIS

COMPARE SUVEN LIFESCIENCES WITH

MARKET STATS